ESC 365 - State of the Art - Current evidence and future perspectives of TAVI

ESC Premium Access

State of the Art - Current evidence and future perspectives of TAVI

Session: 15 years of TAVI: increasing evidence for routine use

Topic: Valvular Heart Disease

Speaker: Professor H. Baumgartner (Muenster, DE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Helmut Baumgartner

University Hospital Munster - UKM, Muenster (Germany)

26 presentations

0 follower

3 more presentations in this session

From first in man transcatheter aortic valve implantation, a 15-year experience.

Speaker: Doctor G. Avinee (Rouen, FR)

Clinical impact of mitral regurgitation before or following transcatheter aortic valve replacement in patients with aortic stenosis: a nationwide multivariable analysis

Speaker: Professor L. Fauchier (Tours, FR)

Early changes in quality of life after transcatheter aortic valve replacement: One-year results from the 3M TAVR Study

Speaker: Doctor S. Lauck (Vancouver, CA)

Access the full session

15 years of TAVI: increasing evidence for routine use

Speakers: Professor H. Baumgartner, Doctor G. Avinee, Professor L. Fauchier, Doctor S. Lauck

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources